Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...
CAMBRIDGE, England--(BUSINESS WIRE)--Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, and Domainex, a multi-award ...
SHIRLEY, NY, USA, November 29, 2023 / EINPresswire.com / -- Profacgen, a leading provider of protein engineering and PROTAC development services, today announced the launch of its comprehensive E3 ...
Membrane proteins are the gateway to cells and are involved in many critical functions. Each membrane protein is unique, and their complexity makes it difficult to fit into a standardized expression ...
Cambridge, UK and Marlborough, MA, 28 May 2025: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ System, has announced a ...
Nuclera extended its Series C with $12M, bringing total to $87M, to expand Protein Discovery with full-format antibody ...
The cell-free protein synthesis (CFPS) market is set to reach USD 308.9 million by 2030, growing at a CAGR of 7.3%. Key growth drivers include rising demand for rapid protein production, adoption of ...
This article is based on a poster originally authored by Sunidhi Shetty, Narasimha Murthy Bandaru, Anna Moberg and Marco Manni, which was presented at ELRIG Drug Discovery 2024 in affiliation with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results